Satoshi Tamauchi

Nagoya, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 89 publications

Drug library screening identifies colchicine and shikonin as therapeutic candidates for methotrexate-resistant choriocarcinoma.

Drug library screening identifies colchicine and shikonin as therapeutic candidates for methotrexate-resistant choriocarcinoma.

Journal: Biochemical and biophysical research communications

Published: July 15, 2026

Annual Report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2023 and Annual Treatment Report for 2018.

Annual Report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2023 and Annual Treatment Report for 2018.

Journal: The journal of obstetrics and gynaecology research

Published: June 08, 2026

Post-CCRT pelvic lymph node size and pathological nodal involvement in cervical cancer.

Post-CCRT pelvic lymph node size and pathological nodal involvement in cervical cancer.

Journal: International journal of clinical oncology

Published: April 30, 2026

Rapid Enlargement of Vulvar Glomus Tumor After Needle Aspiration and Tumor Base Ligation.

Rapid Enlargement of Vulvar Glomus Tumor After Needle Aspiration and Tumor Base Ligation.

Journal: The journal of obstetrics and gynaecology research

Published: February 27, 2026

Impact of Sarcopenia and Pretreatment Skeletal Muscle Loss on Survival in Endometrial Cancer Patients Treated With Immune Checkpoint Inhibitors.

Impact of Sarcopenia and Pretreatment Skeletal Muscle Loss on Survival in Endometrial Cancer Patients Treated With Immune Checkpoint Inhibitors.

Journal: The journal of obstetrics and gynaecology research

Published: February 16, 2026

Mesothelial cells promote peritoneal invasion and metastasis of ascites-derived ovarian cancer cells through spheroid formation.

Mesothelial cells promote peritoneal invasion and metastasis of ascites-derived ovarian cancer cells through spheroid formation.

Journal: Science advances

Published: February 06, 2026

Integrated immunophenotypic and ProMisE molecular profiling as predictors of immune checkpoint inhibitor response in recurrent endometrial cancer.

Integrated immunophenotypic and ProMisE molecular profiling as predictors of immune checkpoint inhibitor response in recurrent endometrial cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: January 29, 2026

Association of germline BRCA and homologous recombination deficiency with hematologic toxicity during platinum-taxane chemotherapy in ovarian cancer.

Association of germline BRCA and homologous recombination deficiency with hematologic toxicity during platinum-taxane chemotherapy in ovarian cancer.

Journal: International journal of clinical oncology

Published: January 22, 2026

DNA Copy Number Profiling in Extracellular Vesicles as Clinical Biomarkers of High-Grade Serous Ovarian Carcinoma.

DNA Copy Number Profiling in Extracellular Vesicles as Clinical Biomarkers of High-Grade Serous Ovarian Carcinoma.

Journal: Journal of extracellular vesicles

Published: November 17, 2025

Annual Report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2022 and Annual Treatment Report for 2017.

Annual Report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2022 and Annual Treatment Report for 2017.

Journal: The journal of obstetrics and gynaecology research

Published: October 08, 2025

Risk factors for recurrent cases of early-stage uterine sarcoma after complete surgical resection.

Risk factors for recurrent cases of early-stage uterine sarcoma after complete surgical resection.

Journal: BMC cancer

Published: October 04, 2025

Genomic insights and therapeutic efficacy of PARP inhibitors in a high-LOH patient-derived xenograft from malignant transformation of ovarian teratoma.

Genomic insights and therapeutic efficacy of PARP inhibitors in a high-LOH patient-derived xenograft from malignant transformation of ovarian teratoma.

Journal: Biochemical and biophysical research communications

Published: September 08, 2025

Showing 1-12 of 89

Last Updated: 09/26/2026